Multidrug-resistant Tuberculosis Patients in Bhutan, August 2011 to July 2012

Authors

  • Jit Bahadur Darnal Mongar Regional Referral Hospital, Mongar, Bhutan
  • W Swaddiwudhipong Department of Community and Social Medicine, Mae Sot General Hospital, Tak Province, Thailand

DOI:

https://doi.org/10.59096/osir.v6i3.263328

Keywords:

tuberculosis, multidrug-resistant, directly observed treatment short-course, Bhutan

Abstract

This study aimed to describe the factors associated with multidrug-resistant tuberculosis (MDR-TB) in Bhutan. The study covered all MDR-TB patients admitted to Gidhakom Hospital, Thimphu from August 2011 to July 2012. Data were collected from MDR-TB registers, laboratory registers and inpatient records as well as from interview with patients about demographic characteristics, history of previous anti-TB treatment, compliance and contact history. There were total 19 MDR-TB patients. Majority of the patients were males (63%). Median age was 25 years for males and 30 years for females. Of the 19 cases, 47% and 37% had contacted with TB case and MDR-TB case in the same house respectively. About 74% reported previous history of anti-TB treatment. Among those with previous treatment, 79% did not comply with the directly observed treatment short-course (DOTS). It was found that 20% of new cases and 50% of previously treated persons were resistant to four first-line drugs. In conclusion, previous anti-TB treatment, non-compliance to DOTS and contact with MDR-TB were observed in majority of the cases. We highlighted the importance of early detection of MDR-TB, providing health education on prevention of disease transmission and strengthening DOTS policy. Investigation on household contacts should be given priority to identify and control the spread of TB.

References

Bhutan. Ministry of Health. Annual health bulletin 2012. Thimphu: Bhutan Ministry of Health; 2012.

World Health Organization. Global tuberculosis report 2012. Geneva: World Health Organization; 2012.

Bhutan. Department of Public Health. Ministry of Health. Guidelines for management of tuberculosis, National TB Control Programme. 5th ed. Thimphu: Ministry of Health; 2010.

World Health Organization, Regional Office for South-East Asia. Tuberculosis control in the South-East Asia region: the regional report 2012. New Dehli: World Health Organization; 2012.

Centers for Disease Control and Prevention. Epi Info. [cited 5 Mar 2013]. <http://wwwn.cdc.gov/epiinfo/html/prevVersion.htm>

Pant R, Pandey KR, Joshi M, Sharma S, Pandey T, Pandey S. Risk factor assessment of multidrug-resistant tuberculosis. J Nepal Health Res Counc. 2009 Apr;7(2):89-92.

Atre SR, D'Souza DT, Vira TS, Chatterjee A, Mistry NF. Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India. Indian J Public Health. 2011 Jan-Mar;55(1):14-21.

Banu S, Mahmud AM, Rahman MT, Hossain A, Uddin MKM, Ahmed T, et al. Multidrug-resistant tuberculosis in admitted patients at a tertiary referral hospital of Bangladesh. PLoS One. 2012 Jul 11;7(7):e40545.

World Health Organization. DOTS - the most effective way to stop TB. [cited 2012 Oct 17]. <http://www.who.int/tb/publications>

Mishra A, Mishra S, Chouksey M, Gautum P, Verma P, Srivastava D, et al. A study of effectiveness of DOTS on tuberculosis patient treated under RNTCP programme. NTI Bulletin. 2007;43(3&4):47-50.

Okanurak K, Kitayaporn D, Wanarangsikul W, Koompong C. Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand. Int J Tuberc Lung Dis. 2007 Jul;11(7):762-8.

Menon S, Dharmshale S, Chande C, Gohil A, Lilani S, Mohammad S, et al. Drug resistance profiles of Mycobacterium tuberculosis isolates to first line anti-tuberculous drugs: A five years study. Lung India. 2012 Jul;29(3):227-31.

Sharma SK, Mohan A. Multidrug-resistant tuberculosis. Indian J Med Res. 2004 Oct;120(4):354-76.

Singla N, Singla R, Jain G, Habib L, Behera D. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India. Int J Tuberc Lung Dis. 2011 Oct;15(10):1326-30.

Lemos AC, Matos ED, Pedral-Sampaio DB, Netto EM. Risk of tuberculosis among household contacts in Salvador, Bahia. Braz J Infect Dis. 2004 Dec;8(6):424-30. Epub 2005 May 9.

Teixeira L, Perkins MD, Johnson JL, Keller R, Palaci M, do Valle Dettoni V, et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2001 Apr;5(4):321-8.

Published

2013-09-27

How to Cite

Darnal, J. B., & Swaddiwudhipong, W. (2013). Multidrug-resistant Tuberculosis Patients in Bhutan, August 2011 to July 2012. Outbreak, Surveillance, Investigation & Response (OSIR) Journal, 6(3), 6–10. https://doi.org/10.59096/osir.v6i3.263328

Issue

Section

Original article